Korean pharmas being active with developing incrementally new drugs while keeping off from new drugs

Published: 2018-05-24 10:41:42

Updated: 2018-05-24 10:41:42

While slowing down with getting approval for new drugs, Korean pharmaceutical companies are being active in developing incrementally modified drugs in combination with other substances.

According to the Ministry of Food and Drug Safety(MFDS), there were 2 products that Korean pharmaceutical companies developed as a new drug: Ildong Pharmaceutical’s ‘Besivo Tab’ and Kolon Life Science’s ‘Invoss...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.